These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Chemoprophylaxis and chemotherapy of common colds caused by rhinoviruses: overview and outlook]. Werner GH Bull Acad Natl Med; 1992 May; 176(5):669-81. PubMed ID: 1330221 [TBL] [Abstract][Full Text] [Related]
4. Hand-to-hand transmission of rhinovirus colds. Gwaltney JM; Moskalski PB; Hendley JO Ann Intern Med; 1978 Apr; 88(4):463-7. PubMed ID: 205151 [TBL] [Abstract][Full Text] [Related]
5. Rhinovirus inactivation by nasal tissues treated with virucide. Hayden GF; Gwaltney JM; Thacker DF; Hendley JO Antiviral Res; 1985 Apr; 5(2):103-9. PubMed ID: 2990332 [TBL] [Abstract][Full Text] [Related]
6. Virucidal hand treatments for prevention of rhinovirus infection. Turner RB; Hendley JO J Antimicrob Chemother; 2005 Nov; 56(5):805-7. PubMed ID: 16159927 [TBL] [Abstract][Full Text] [Related]
7. Interruption of transmission of rhinovirus colds among human volunteers using virucidal paper handkerchiefs. Dick EC; Hossain SU; Mink KA; Meschievitz CK; Schultz SB; Raynor WJ; Inhorn SL J Infect Dis; 1986 Feb; 153(2):352-6. PubMed ID: 3003208 [No Abstract] [Full Text] [Related]
8. Transmission route of rhinovirus - the causative agent for common cold. A systematic review. Andrup L; Krogfelt KA; Hansen KS; Madsen AM Am J Infect Control; 2023 Aug; 51(8):938-957. PubMed ID: 36535318 [TBL] [Abstract][Full Text] [Related]
9. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519 [TBL] [Abstract][Full Text] [Related]
10. Effects on the nasal mucosa of upper respiratory viruses (common cold). Winther B Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434 [TBL] [Abstract][Full Text] [Related]
11. Literature review: the common cold. Hilding DA Ear Nose Throat J; 1994 Sep; 73(9):639-43, 46-7. PubMed ID: 7988393 [TBL] [Abstract][Full Text] [Related]
12. Purified interferon as protection against rhinovirus infection. Scott GM; Phillpotts RJ; Wallace J; Secher DS; Cantell K; Tyrrell DA Br Med J (Clin Res Ed); 1982 Jun; 284(6332):1822-5. PubMed ID: 6177374 [TBL] [Abstract][Full Text] [Related]
13. New considerations in the treatment and prevention of rhinovirus infections. Turner RB Pediatr Ann; 2005 Jan; 34(1):53-7. PubMed ID: 15693216 [TBL] [Abstract][Full Text] [Related]
14. [Human rhinovirus diseases--epidemiology, treatment and prevention]. Stock I Med Monatsschr Pharm; 2014 Feb; 37(2):44-53. PubMed ID: 24624610 [TBL] [Abstract][Full Text] [Related]
15. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. Peltola V; Waris M; Osterback R; Susi P; Ruuskanen O; Hyypiä T J Infect Dis; 2008 Feb; 197(3):382-9. PubMed ID: 18248302 [TBL] [Abstract][Full Text] [Related]
16. Chemical disinfection to interrupt transfer of rhinovirus type 14 from environmental surfaces to hands. Sattar SA; Jacobsen H; Springthorpe VS; Cusack TM; Rubino JR Appl Environ Microbiol; 1993 May; 59(5):1579-85. PubMed ID: 8390817 [TBL] [Abstract][Full Text] [Related]
17. An update on the pathophysiology of rhinovirus upper respiratory tract infections. van Kempen M; Bachert C; Van Cauwenberge P Rhinology; 1999 Sep; 37(3):97-103. PubMed ID: 10567986 [TBL] [Abstract][Full Text] [Related]
18. Transmission route of rhinovirus type 39 in a monodispersed airborne aerosol. Bischoff WE Infect Control Hosp Epidemiol; 2010 Aug; 31(8):857-9. PubMed ID: 20569111 [TBL] [Abstract][Full Text] [Related]